Blume Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $36K | Hold |
|
|||||
|
2024
Q3 | $39.5K | Sell |
|
|||||
|
2024
Q2 | $46.4K | Hold |
|
|||||
|
2024
Q1 | $47.4K | Sell |
|
|||||
|
2023
Q4 | $89.3K | Sell |
|
|||||
|
2023
Q3 | $126K | Sell |
|
|||||
|
2023
Q2 | $744K | Sell |
|
|||||
|
2023
Q1 | $691K | Hold |
|
|||||
|
2022
Q4 | $753K | Sell |
|
|||||
|
2022
Q3 | $739K | Buy |
|
|||||
|
2022
Q2 | $213K | Sell |
|
|||||
|
2022
Q1 | $281K | Sell |
|
|||||
|
2021
Q4 | $356K | Buy |
|
|||||
|
2021
Q3 | $331K | Hold |
|
|||||
|
2021
Q2 | $356K | Hold |
|
|||||
|
2021
Q1 | $357K | Sell |
|
|||||
|
2020
Q4 | $381K | Sell |
|
|||||
|
2020
Q3 | $335K | Buy |
|
|||||
|
2020
Q2 | $334K | Sell |
|
|||||
|
2020
Q1 | $232K | Buy |
|
|||||
|
2019
Q4 | $276K | Buy |
|
|||||
|
2019
Q3 | $175K | Sell |
|
|||||
|
2019
Q2 | $204K | Hold |
|
|||||
|
2019
Q1 | $211K | Buy |
|
|||||
|
2018
Q4 | $146K | Buy |
|
|||||
|
2018
Q3 | $190K | Hold |
|
|||||
|
2018
Q2 | $188K | Buy |
|
|||||
|
2018
Q1 | $167K | Buy |
|
|||||
|
2017
Q4 | $9K | Hold |
|
|||||
|
2017
Q3 | $9K | Hold |
|
|||||
|
2017
Q2 | $8K | Hold |
|
|||||
|
2017
Q1 | $7K | Hold |
|
|||||
|
2016
Q4 | $6K | Hold |
|
|||||
|
2016
Q3 | $7K | Hold |
|
|||||
|
2016
Q2 | $6K | Sell |
|
|||||
|
2016
Q1 | $21K | Sell |
|
|||||
|
2015
Q4 | $49K | Hold |
|
|||||
|
2015
Q3 | $44K | Hold |
|
|||||
|
2015
Q2 | $59K | Hold |
|
|||||
|
2015
Q1 | $53K | Hold |
|
|||||
|
2014
Q4 | $44K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $142K | Buy |
|